A 7-kDa region of the bacteriophage T7 gene 4 protein is required for primase but not for helicase activity.

Por Bernstein, J A, Richardson, C C
Publicado em 1988

The utility of monitoring trimellitic anhydride (TMA)-specific IgG to predict IgE-mediated sensitization in an immunosurveillance program

Por Ghosh, D., Clay, C., Bernstein, J. A.
Publicado no Allergy (2017)

Template requirements for in vivo replication of adenovirus DNA.

Por Bernstein, J A, Porter, J M, Challberg, M D
Publicado em 1986

Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence...

Por Maurer, M., Sofen, H., Ortiz, B., Kianifard, F., Gabriel, S., Bernstein, J.A.
Publicado no J Eur Acad Dermatol Venereol (2017)

Rapid Implementation of Inpatient Electronic Physician Documentation at an Academic Hospital

Por Hahn, J.S., Bernstein, J.A., McKenzie, R.B., King, B.J., Longhurst, C.A.
Publicado em 2012

Immune responses in farm workers after exposure to Bacillus thuringiensis pesticides.

Por Bernstein, I L, Bernstein, J A, Miller, M, Tierzieva, S, Bernstein, D I, Lummus, Z, Selgrade, M K, Doerfler, D L, Seligy, V L
Publicado em 1999

Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate

Por Zuraw, B. L., Cicardi, M., Longhurst, H. J., Bernstein, J. A., Li, H. H., Magerl, M., Martinez‐Saguer, I., Rehman, S. M. M., Staubach, P., Feuersenger, H., Parasrampuria, R., Sidhu, J., Edelman, J., Craig, T.
Publicado no Allergy (2015)

Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial

Por Malbrán, A, Riedl, M, Ritchie, B, Smith, W B, Yang, W, Banerji, A, Hébert, J, Gleich, G J, Hurewitz, D, Jacobson, K W, Bernstein, J A, Khan, D A, Kirkpatrick, C H, Resnick, D, Li, H, Fernández Romero, D S, Lumry, W
Publicado no Clin Exp Immunol (2014)

Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS‐2 study

Por Riedl, M. A., Aygören‐Pürsün, E., Baker, J., Farkas, H., Anderson, J., Bernstein, J. A., Bouillet, L., Busse, P., Manning, M., Magerl, M., Gompels, M., Huissoon, A. P., Longhurst, H., Lumry, W., Ritchie, B., Shapiro, R., Soteres, D., Banerji, A., Cancian, M., Johnston, D. T., Craig, T. J., Launay, D., Li, H. H., Liebhaber, M., Nickel, T., Offenberger, J., Rae, W., Schrijvers, R., Triggiani, M., Wedner, H. J., Dobo, S., Cornpropst, M., Clemons, D., Fang, L., Collis, P., Sheridan, W. P., Maurer, M.
Publicado no Allergy (2018)

Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema

Por Cicardi, M., Banerji, A., Bracho, F., Malbrán, A., Rosenkranz, B., Riedl, M., Bork, K., Lumry, W., Aberer, W., Bier, H., Bas, M., Greve, J., Hoffmann, T.K., Farkas, H., Reshef, A., Ritchie, B., Yang, W., Grabbe, J., Kivity, S., Kreuz, W., Levy, R.J., Luger, T., Obtulowicz, K., Schmid-Grendelmeier, P., Bull, C., Sitkauskiene, B., Smith, W.B., Toubi, E., Werner, S., Anné, S., Björkander, J., Bouillet, L., Cillari, E., Hurewitz, D., Jacobson, K.W., Katelaris, C.H., Maurer, M., Merk, H., Bernstein, J.A., Feighery, C., Floccard, B., Gleich, G., Hébert, J., Kaatz, M., Keith, P., Kirkpatrick, C.H., Langton, D., Martin, L., Pichler, C., Resnick, D., Wombolt, D., Fernández Romero, D.S., Zanichelli, A., Arcoleo, F., Knolle, J., Kravec, I., Dong, L., Zimmermann, J., Rosen, K., Fan, W.-T.
Publicado no N Engl J Med (2010)